<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1467284</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Transition care in primary immunodeficiencies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Burns</surname>
<given-names>Siobhan Oisin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/257764"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mahlaoui</surname>
<given-names>Nizar</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/257931"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Royal Free London National Health System (NHS) Foundation Trust</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Pediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants University Hospital, Assistance Publique-H&#xf4;pitaux de Paris (AP-HP)</institution>, <addr-line>Paris</addr-line>, <country>France</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>French National Reference Center for Primary Immunodeficiencies (CEREDIH), Necker-Enfants University Hospital, Assistance Publique-H&#xf4;pitaux de Paris (AP-HP)</institution>, <addr-line>Paris</addr-line>, <country>France</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Transition Care platform for Adolescents and Young Adults with Rare or Chronic Diseases &#xab; La Suite &#xbb;, Necker-Enfants University Hospital, Assistance Publique-H&#xf4;pitaux de Paris (AP-HP)</institution>, <addr-line>Paris</addr-line>, <country>France</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Fabio Candotti, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Nizar Mahlaoui, <email xlink:href="mailto:nizar.mahlaoui@aphp.fr">nizar.mahlaoui@aphp.fr</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>08</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1467284</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>07</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>08</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Burns and Mahlaoui</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Burns and Mahlaoui</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/47580/transition-care-in-primary-immunodeficiencies/magazine" ext-link-type="uri">Editorial on the Research Topic <article-title>Transition care in primary immunodeficiencies</article-title>
</related-article>
<kwd-group>
<kwd>primary immunodeficiencies</kwd>
<kwd>transitional care</kwd>
<kwd>inborn errors of immunity (IEI)</kwd>
<kwd>continuity of care</kwd>
<kwd>adolescents and young adult (AYA)</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="3"/>
<page-count count="2"/>
<word-count count="798"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Primary Immunodeficiencies</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Transition has been defined as &#x2018;a purposeful, planned process that addresses the medical, psychological, and educational/vocational needs of adolescents and young adults (AYA) with chronic physical and medical conditions as they move from child-centered to adult-oriented health care systems&#x2019; (<xref ref-type="bibr" rid="B1">1</xref>).</p>
<p>Inborn Errors of Immunity (IEI) are chronic rare disorders that result in impaired, excessive or complex dysregulated immune responses. Primary Immunodeficiencies (PID) represent the majority of IEI and are frequently diagnosed during childhood or adolescence. It has now been well established that, despite tremendous improvements in patient diagnosis, treatment and survival, complications occur throughout the life course of patients with all forms of PIDs (<xref ref-type="bibr" rid="B2">2</xref>), requiring long term multidisciplinary management. While transitioning from pediatric care setting to adult services, patients, caregivers, but also healthcare professionals may face, sometimes unforeseen, challenges as clinical phenotype is highly variable and not always predictable and natural history data is sparse in this group of rare diseases.</p>
<p>Data on transition (especially evidence-based) and recommendations in the field of PID/IEI are scarce. A recent survey published by the ERN RITA in 2023 (<xref ref-type="bibr" rid="B3">3</xref>) demonstrated that transition services for children with IEI in Europe are available in many countries. Approximately 75% of PID services in Europe reported having a defined transition process. In this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1209315">Chan et&#xa0;al.</ext-link> from Southeast Asia contrasted transition care in the context of different healthcare systems. Almost half the countries in their study reported having no practice of transition care. One of the major challenges was the reluctancy of patients and caregivers to adapt to unfamiliarized adult healthcare systems. Inadequate ratio of adult immunologists and facilities for transfer as well as lack of training in transition care were also barriers to smooth transition.</p>
<p>It is now well established that an effective process is of utmost importance to improve long term outcome of AYA with chronic conditions. Timing and progression of transition preparation during adolescence is key. Some tools assessing youth readiness for transition are available (mostly in English language). However, both the study by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1209315">Chan et&#xa0;al.</ext-link> and the previous ERN RITA survey highlighted lack of formal transition guidelines for PID as a gap that needs to be addressed (<xref ref-type="bibr" rid="B3">3</xref>). In this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1263349">Mej&#xed;a Gonz&#xe1;lez et&#xa0;al.</ext-link>, propose a framework for transition of patients with combined immunodeficiencies with syndromic features, who typically have complex chronic conditions adding to the challenges of ensuring a smooth transition pathway. Adult services often have less experience with this group of conditions which require extensive multidisciplinary care across hospital and community settings. The authors recommend a PID-Transition Process Coordinator and a PID-Transition Case Manager as cornerstones of the transition process.</p>
<p>Building on considerations for specific groups of PID patients, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1211872">Alderson et&#xa0;al.</ext-link>, provide insight for transitioning young adults with learning disabilities. The authors emphasize the importance of supportive interactions from clinicians and family&#xa0;members so that those with both a learning disability and&#xa0;an immunodeficiency can have a transition process that accommodates their specific requirements. The need for medical professional training as well as ongoing psychological support for adolescents with learning disabilities and their families are key for improving the transition experience in this group of PID.</p>
<p>To date, there is relatively little data about patient experience of transition in PID. In this Research Topic, two studies address this gap. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1211524">Ouimet et&#xa0;al.</ext-link> from Montr&#xe9;al, Quebec, Canada examine the common transition difficulties for IEI patients with chronic illness which encompassed challenges of changing health care teams as well as issues around developing independence. The authors outline a set of recommendations reported by youths and their families. These include having a joint clinic with both pediatric and adult team, meeting health care professionals from the adult clinical unit, providing information about the adult healthcare setting (including having clear instructions on how and who to contact in case of emergencies). A transition coordinator (such as a dedicated nurse) and connection with a network of youth (and caregivers) who transitioned recently for peer meetings were also recommended. Self-advocacy and medication management were reported by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2024.1270451">King et&#xa0;al.</ext-link> as areas of challenge identified by patients during transition. Their study additionally highlighted the specific aspect of unnecessary and costly duplication of investigations (especially laboratory testing) in new transitioning patients. They suggest that implementing a formal transition protocol could minimize these costs (8). These studies highlight that further research to understand the parents&#x2019; and caregivers&#x2019; point of view, in order to inform improvements in transition for PID and to develop formal guidelines, is needed.</p>
<p>Contributions of multidisciplinary health care professionals &#x2014; pediatric and adult teams, clinical psychologists, and ethicists &#x2014; alongside contributions of colleagues from different health care systems greatly enriched the perspectives on this topic, highlighting the importance of standardized integration of transition practice towards betterment of transiting PID patients into adulthood.</p>
</body>
<back>
<sec id="s1" sec-type="author-contributions">
<title>Author contributions</title>
<p>NM: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. SB:  Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s2" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s3" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blum</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Garell</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hodgman</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Jorissen</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Okinow</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Orr</surname> <given-names>DP</given-names>
</name>
<etal/>
</person-group>. <article-title>Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine</article-title>. <source>J Adolesc Health Off Publ Soc Adolesc Med</source>. (<year>1993</year>) <volume>14</volume>:<fpage>570&#x2212;6</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/1054-139X(93)90143-D</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alligon</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mahlaoui</surname> <given-names>N</given-names>
</name>
<name>
<surname>Courteille</surname> <given-names>V</given-names>
</name>
<name>
<surname>Costes</surname> <given-names>L</given-names>
</name>
<name>
<surname>Afonso</surname> <given-names>V</given-names>
</name>
<name>
<surname>Randrianomenjanahary</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>An appraisal of the frequency and severity of noninfectious manifestations in primary immunodeficiencies: A study of a national retrospective cohort of 1375 patients over 10 years</article-title>. <source>J Allergy Clin Immunol</source>. (<year>2022</year>) <volume>149</volume>:<fpage>2116&#x2212;25</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaci.2021.12.790</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Israni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nicholson</surname> <given-names>B</given-names>
</name>
<name>
<surname>Mahlaoui</surname> <given-names>N</given-names>
</name>
<name>
<surname>Obici</surname> <given-names>L</given-names>
</name>
<name>
<surname>Rossi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lachmann</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Transition Working Group Consortium. Current transition practice for primary immunodeficiencies and autoinflammatory diseases in Europe. A RITA-ERN survey</article-title>. <source>J Clin Immunol</source>. (<year>2022</year>) <page-range>206&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10875-022-01345-y</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>